Every year the Social Security Administration calculates how inflation affects the cost of living and then adjusts benefits for the near 75 million Americans
Social Security’s 2026 COLA Is 2.8%, but Some Retirees Won’t Get it All
ShutterstockProfessional / Shutterstock.com Social Security benefits will increase 2.8% in 2026. The average Social Security benefit will rise from $2,015 to $2,071 per month.
3 High Growth Revenue Stocks That Wall Street Loves
Third quarter revenue soared by 17% year-over-year (YOY) past $1 billion, and management forecasts that revenue for the next quarter will top $1.3 billion.
Stock Market Outlook Next Week (Nov 24–28): Sensex, Nifty Brace for Volatility with GDP Data, US Trade Talks
On the technical front, the Nifty ended the second consecutive week on a strong note, gaining 0.61% and reaching a 14-month high. The index
Blue Foundry stock soars after Fulton Financial acquisition deal
Under the terms of the agreement, each share of Blue Foundry common stock will be exchanged for 0.6500 shares of Fulton common stock, valuing
Fulton Financial and Blue Foundry to Combine in $243M Deal
Fulton Financial agreed to acquire fellow community bank Blue Foundry in an all-stock deal valued at $243 million, or $11.67 per Blue Foundry common
Stock Market Live November 27: S&P 500 (VOO) Rises to Start Holiday-Shortened Week
The S&P 500 closed down 2% for the week on Friday, despite a last minute rebound on the week’s final trading day. That positive
Merck, Caterpillar share gains lead Dow’s 180-point jump
The Dow Jones Industrial Average is climbing Monday afternoon with shares of Merck and Caterpillar seeing positive momentum for the index. The Dow was
Exclusive-Blue Owl considers reviving merger of private credit funds, contingent on fund’s share price, sources say
By Anirban Sen NEW YORK (Reuters) -Blue Owl Capital is considering reviving a plan to merge two of its private credit funds if the
Novo Nordisk Hits A 10-Year Low – I Think The Market Is Making A Mistake
Novo Nordisk’s stock fell after semaglutide’s Alzheimer’s news. Click here for how strong fundamentals and growth catalysts make NVO a compelling long-term Hold.